3SBio Inc. Receives NMPA Approval for Nalfurafine Tablets to Treat Hemodialysis-Related Pruritus
China-based 3SBio Inc. (HKG: 1530) has announced receiving marketing approval from the National Medical Products...
China-based 3SBio Inc. (HKG: 1530) has announced receiving marketing approval from the National Medical Products...
Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276), a leading pharmaceutical company based in China, has...
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) has announced receiving marketing approval in China for...
US pharmaceutical firm AbbVie (NYSE: ABBV) has announced receiving market approval from the National Medical...
Luye Pharma Group (HKG: 2186) has announced that it has received market approval from the...
China-based Huadong Medicine Co., Ltd (SHE: 000963) has announced that it has received additional indication...
Shanghai-based biotech firm Abbisko Therapeutics Co., Ltd (HKG: 2256) has announced that it has received...
China-based Jacobio Pharma (HKG: 1167) has announced that it has received the green light from...
China-based InnoCare Pharma (HKG: 9969, SHA: 688428) has announced a significant milestone in the clinical...
The National Medical Products Administration (NMPA) has approved pitolisant as a treatment for excessive daytime...
China-based Ascentage Pharma (HKG: 6855) has announced that it has received approval from the National...
Xiamen-based Amoytop Biotech Co. Ltd (SHA: 688278) has received marketing approval from the National Medical...
The China’s Center for Drug Evaluation (CDE) website has indicated that Huadong Medicine Co., Ltd...
Transcenta Holding Ltd (HKG: 6628), a China-based biopharmaceutical company, has presented progression-free survival (PFS) data...
China-based Hybio Pharmaceutical Co., Ltd (SHE: 300199) has announced that the National Medical Products Administration...
Innovent Biologics, Inc. (HKG: 1801) and IASO Biotherapeutics have announced that they have received marketing...
SciClone Pharmaceuticals Inc. (Nasdaq: SCLN) has reached a significant milestone with the first prescription of...
Zai Lab Ltd (NASDAQ: ZLAB; HKG: 9688), a China-based biopharmaceutical company, has announced that the...
InnoCare Pharma (HKG: 9969; SHA: 688428) and Keymed Biosciences Inc., (HKG: 2162) have announced a...
Jiangsu Hengrui Medicine Co., Ltd (SHA: 600276), a leading China-based pharmaceutical company, has announced that...